Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia
NCT02511496 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2800
Last updated 2015-07-31
Summary
This study evaluates the current situation and follow-up of chronic hepatitis C virus (HCV) infection in patients co-infected with human immunodeficiency virus (HIV) in Andalusia.
Conditions
- Chronic Hepatitis C
- Human Immunodeficiency Virus (HIV)
Sponsors & Collaborators
-
Maimónides Biomedical Research Institute of Córdoba
lead OTHER
Principal Investigators
-
Antonio Rivero Juárez · Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC)
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2020-11-30
- Completion
- 2020-12-31
More Related Trials
-
Pilot Study of Patients Chronic Hepatitis C in Co-infected HIV Patients Relapsers After Previous Therapies
NCT00530972 ·Status: COMPLETED ·Phase: PHASE4
-
Retreatment With High Doses of pegIFN Alfa-2a and Ribavirin of Previous Nonresponders HIV-coinfected Patients With Cirrhosis Due to HCV 1-4
NCT01006031 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Thalidomide Plus Peginterferon and Ribavirin in Patients With Interferon Resistance
NCT00856804 ·Status: UNKNOWN ·Phase: PHASE2
-
Tools to Identify People At Risk or Already Infected with HIV and HCV
NCT06528626 ·Status: RECRUITING ·Phase: NA
-
HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With Fosamprenavir
NCT01222611 ·Status: COMPLETED ·Phase: PHASE4
-
Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
NCT01980290 ·Status: COMPLETED
-
HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy
NCT04768517 ·Status: UNKNOWN
-
Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients.
NCT00422838 ·Status: COMPLETED
-
Register of Telaprevir and Boceprevir in Routine Clinical Practice
NCT02004379 ·Status: COMPLETED
-
Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus Infection
NCT00164060 ·Status: TERMINATED
-
Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C
NCT00209755 ·Status: TERMINATED ·Phase: NA
-
Different PEG-interferon and Ribavirin Schedules for Chronic Hepatitis C in the Real Clinical Practice.
NCT01195181 ·Status: COMPLETED ·Phase: PHASE4
-
Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting
NCT00222859 ·Status: COMPLETED
-
Prediction of Liver-related Outcomes After HCV Cure
NCT04460157 ·Status: UNKNOWN
-
Study to Assess Monoclonal B-Cell Lymphocytosis in Individuals With Chronic Hepatitis C
NCT06564051 ·Status: TERMINATED
-
Outcomes in Liver Disease Patient With and Without HIV Co-infection-Sub Study 2: HCV Treatment: Health Related Quality
NCT02427204 ·Status: COMPLETED
-
Efficacy and Safety of Therapy Against HCV Based on Direct-acting Antivirals in Real-life Conditions
NCT02333292 ·Status: COMPLETED
-
Hepatic Safety of Eviplera® in HIV/Hepatitis C (HCV)-Coinfected Patients Without HCV Treatment in the "The HEPAVIR HEPATIC SAFETY Cohort."
NCT02196064 ·Status: COMPLETED
-
Study on Immunopathogenesis in HIV and Hepatitis C Coinfection
NCT01296529 ·Status: COMPLETED
-
An Efficacy and Safety Study of Telaprevir in Patients Infected With Both Chronic Hepatitis C Virus (HCV-1) and Human Immunodeficiency Virus (HIV-1)
NCT01513941 ·Status: COMPLETED ·Phase: PHASE3
-
Long Term Follow-up of Hepatitis C Cured Patients
NCT03246048 ·Status: COMPLETED
-
Antiviral Therapy in Decompensated Hepatitis C Virus (HCV) Cirrhosis
NCT00301509 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Natural History and Treatment of Acute Hepatitis C Virus (HCV) in HIV-positive Individuals
NCT01289652 ·Status: UNKNOWN
-
Leukapheresis for Research on HCV-Coinfected Patients
NCT00076427 ·Status: COMPLETED
-
Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens
NCT02505243 ·Status: COMPLETED